All compounds
ApprovedPDE5 inhibitor

Vardenafil

Levitra, Staxyn

Short-acting, highly selective PDE5 inhibitor. Sharper on and sharper off than tadalafil, with less visual disturbance than sildenafil.

FDA-approved

FDA-approved for erectile dysfunction. Available generically.

What it is

Vardenafil is a PDE5 inhibitor with the same core mechanism as tadalafil and sildenafil, differing in selectivity and duration.

How the three compare

SildenafilVardenafilTadalafil
Half-life~4 h~4-5 h~17.5 h
Onset30-60 min30-60 min30-120 min
Food interactionSignificant - fat delays itModerateMinimal
Daily dosing viableNoNoYes
Distinctive side effectBlue-tinted vision (PDE6 cross-reactivity)QT prolongation signalBack and muscle ache

Vardenafil's selectivity for PDE5 over PDE6 - the retinal enzyme - is higher than sildenafil's, which is why the blue-vision effect is much less common. That selectivity is its main argument.

Practical notes

  • This is a situational drug. If you want continuous coverage, tadalafil's half-life is the reason it exists; vardenafil cannot do that job.
  • Food matters less than with sildenafil but is not irrelevant - a heavy fatty meal still delays onset.
  • The QT signal is the reason to check your other medications. Combined with other QT-prolonging drugs, or in known long QT syndrome, another agent is the better choice.
  • Nitrates, absolutely not. Same as the rest of the class.

Side effects and warning signs

Commonly reported

  • Headache
  • Flushing
  • Nasal congestion
  • Indigestion
  • Dizziness from blood pressure reduction

Stop and get medical help

  • Erection lasting over 4 hours - priapism is an emergency
  • Sudden vision or hearing loss
  • QT interval prolongation - vardenafil carries more of this signal than the other PDE5 inhibitors, which matters if you take other QT-prolonging drugs or have a known conduction abnormality
  • Absolute contraindication with nitrates, including poppers

Sources

  1. FDA prescribing information - Levitra (vardenafil)regulatory